REPLIGEN CORP (RGEN) Stock Income Statement
NASDAQ:RGEN - Nasdaq - US7599161095 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 803.61M | 634.44M | 632.36M | 801.50M | 670.50M | |||
| Cost Of Goods | 393.57M | 315.77M | 323.54M | 345.80M | 279.30M | |||
| Gross Profit | 410.04M | 318.67M | 308.83M | 455.70M | 391.30M | |||
| Operating Expenses | 389.44M | 306.62M | 228.92M | 259.80M | 213.40M | |||
| Research and Development | 54.87M | 42.75M | 42.61M | 43.90M | 34.30M | |||
| Selling, General, and Administrative Expenses | 331.38M | 260.68M | 216.89M | 188.80M | 157.20M | |||
| Operating Income | 20.61M | 12.05M | 79.90M | 196.00M | 177.80M | |||
| Interest Income/Expense | 14.90M | 13.25M | 13.56M | 5.80M | -12.50M | |||
| Other Income/Expense | -5.69M | -5.41M | 8.12M | -11.30M | -1.20M | |||
| Non Recurring Items | -48.91M | -46.94M | -44.88M | 28.70M | -10.60M | |||
| Income Before Taxes | -19.09M | -27.04M | 56.71M | 219.10M | 153.50M | |||
| Income Tax | 592.00K | -1.52M | 21.11M | 33.20M | 25.30M | |||
| Net Income | -19.68M | -25.51M | 35.60M | 186.00M | 128.30M | |||
| EBITDA | 113.56M | 98.62M | 147.99M | 247.00M | 216.20M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.35 | -0.46 | 0.63 | 3.24 | 2.24 | |||
| Non GAAP EPS | 1.59 | 1.48 | 1.73 | 3.28 | 3.06 | |||
| Statistics | ||||||||
| Gross Profit Margin | 51.03% | 50.23% | 48.84% | 56.86% | 58.36% | |||
| Profit Margin | -2.45% | -4.02% | 5.63% | 23.21% | 19.13% | |||
| Operating Profit Margin | 2.56% | 1.90% | 12.64% | 24.45% | 26.52% | |||
All data in USD